Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007898
Filing Date
2025-05-15
Accepted
2025-05-15 16:34:46
Documents
103
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fbio-20250331x10q.htm   iXBRL 10-Q 2998835
2 EX-31-1 fbio-20250331xex31d1.htm EX-31.1 13778
3 EX-31-2 fbio-20250331xex31d2.htm EX-31.2 14462
4 EX-32-1 fbio-20250331xex32d1.htm EX-32.1 8079
5 EX-32-2 fbio-20250331xex32d2.htm EX-32.2 8016
  Complete submission text file 0001558370-25-007898.txt   12953757

Data Files

Seq Description Document Type Size
6 EX-101.SCH fbio-20250331.xsd EX-101.SCH 106173
7 EX-101.CAL fbio-20250331_cal.xml EX-101.CAL 77369
8 EX-101.DEF fbio-20250331_def.xml EX-101.DEF 402742
9 EX-101.LAB fbio-20250331_lab.xml EX-101.LAB 730859
10 EX-101.PRE fbio-20250331_pre.xml EX-101.PRE 595318
106 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20250331x10q_htm.xml XML 2408597
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 25954316
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)